Skip to main navigation Skip to search Skip to main content

Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology

  • on behalf the COPD Assembly of the APSR
  • Bach Mai Hospital
  • University of Indonesia
  • Yamaguchi University
  • Veterans General Hospital-Taipei

Research output: Contribution to journal › Article › peer-review

42 Scopus citations

Abstract

Chronic obstructive pulmonary disease (COPD) is a major disease in Asia. However, how to manage specifically Asian COPD patients has not been proposed. Awareness of COPD is very low and underdiagnosis/undertreatment is common in Asian countries. Low utilization of pulmonary function test and inhalers is also a problem. Moreover, high smoking prevalence and air pollution are barriers to managing Asian patients with COPD. The relatively low body mass index of Asian patients with COPD can increase their risk for experiencing adverse effects from COPD drugs. Physicians should consider the unique features of Asian populations with COPD such as the high prevalence rates of bronchiectasis and tuberculosis-destroyed lungs, biomass smoke exposure and parasitic infection.

Original languageEnglish
Pages (from-to)1018-1025
Number of pages8
JournalRespirology
Volume24
Issue number10
DOIs
StatePublished - 1 Oct 2019

Bibliographical note

Publisher Copyright:
© 2019 Asian Pacific Society of Respirology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • air pollution
  • bronchiectasis
  • chronic obstructive pulmonary disease
  • tuberculosis

Fingerprint

Dive into the research topics of 'Management of COPD in Asia: A position statement of the Asian Pacific Society of Respirology'. Together they form a unique fingerprint.

Cite this